The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,742.00
Bid: 14,460.00
Ask: 9,640.00
Change: -308.00 (-2.56%)
Spread: -4,820.00 (-33.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-U.S. dollar skids from four-week high; euro gains

Wed, 09th Sep 2020 20:17

* Euro rises after Bloomberg report on ECB forecasts
* Sterling rises after EU says will not suspend Brexit talks
* BoC keeps rates steady; Canadian dollar up
* U.S. dollar to be well-supported until year-end -analyst
* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E

(Adds new comment, updates prices)
By Gertrude Chavez-Dreyfuss
NEW YORK, Sept 9 (Reuters) - The U.S. dollar slid from a four-week high on Wednesday, led by losses
against the euro after a news report said European Central Bank officials have become more confident in
their outlook for the region's recovery.
The safe-haven greenback was also pressured by improving risk sentiment as U.S. stocks rebounded from
a sharp sell-off and as higher crude oil prices prompted gains in commodity currencies.
Some analysts, however, expect the dollar to hold recent gains after a steep fall the last few months.
Since the beginning of September, the dollar has risen 2% against a currency basket.
Citing euro area officials, Bloomberg News reported on Wednesday that the ECB's upcoming projections
for output and inflation will show only slight changes to the June outlook, with gross domestic product
for this year to be revised higher.
The report, which came ahead of Thursday's ECB monetary policy meeting, spurred euro buying.
"It seems like there is still strong optimism about a euro zone recovery," said Edward Moya, senior
market analyst at OANDA in New York. "It's going to need more support, but things are not as bad as
initially believed."
In afternoon trading, the euro rose 0.3% against the dollar to $1.1805, which pushed the
dollar index down 0.3% at 93.265. Earlier on Wednesday, the index advanced to a four-week peak of 93.664.
That said, Scotiabank chief FX strategist Shaun Osborne believes the dollar will remain firmer
relative to the major currencies into the year-end, citing extreme bets against it in the speculative
market.
"We can see the dollar well-supported, primarily because positioning has been quite heavily skewed,
especially towards the euro," Osborne said.
"I don't think with this pullback in the euro, we have seen anywhere near tidying up those significant
positions."
He also said the dollar tends to rally ahead of a U.S. presidential election, at least since the
1980s.
Against other currencies, the dollar fell 0.5% to 0.9130 Swiss franc.
The dollar rose 0.2% against the yen to 106.20 yen. Earlier, the safe-haven yen gained after
news of a delay in the roll-out of a COVID vaccine.
AstraZeneca Plc said it paused global trials, including large late-stage trials, of its
experimental coronavirus vaccine due to an unexplained illness in a study participant.
Sterling, meanwhile, briefly rose back above $1.30 after an EU statement said it would not suspend
Brexit negotiations over the British government's new internal market bill. The pound was last up 0.1% at
$1.2992.
The pound earlier fell to a six-week low, as new legislation on Britain's post-Brexit plans stoked
fears that trade talks with the European Union would derail.
Commodity currencies, one of many barometers to gauge risk appetite, gained as crude prices rose and
stocks advanced.
The Australian and New Zealand dollars rose against the greenback, both gaining 0.8% to US$0.7272
and US$0.6669, respectively.
The Canadian dollar recovered against the U.S. currency, which fell 0.6% to C$1.3160, after
the Bank of Canada held interest rates steady at 0.25% on Wednesday.

========================================================
Currency bid prices at 3:01 PM (1901 GMT)
Description RIC Last U.S. Close Pct Change YTD Pct High Bid Low Bid
Previous Change
Session
Euro/Dollar EUR= $1.1807 $1.1779 +0.24% +5.32% +1.1833 +1.1754
Dollar/Yen JPY= 106.2000 106.0100 +0.18% -2.43% +106.2700 +105.8000
Euro/Yen EURJPY= 125.40 124.83 +0.46% +2.83% +125.6400 +124.4500
Dollar/Swiss CHF= 0.9123 0.9173 -0.55% -5.73% +0.9190 +0.9124
Sterling/Dollar GBP= 1.2990 1.2987 +0.02% -2.03% +1.3023 +1.2886
Dollar/Canadian CAD= 1.3153 1.3232 -0.60% +1.29% +1.3259 +1.3148
Australian/Doll AUD= 0.7274 0.7214 +0.83% +3.62% +0.7287 +0.7193
ar
Euro/Swiss EURCHF= 1.0773 1.0804 -0.29% -0.73% +1.0817 +1.0775
Euro/Sterling EURGBP= 0.9087 0.9068 +0.21% +7.49% +0.9130 +0.9060
NZ NZD= 0.6670 0.6618 +0.79% -0.98% +0.6685 +0.6602
Dollar/Dollar
Dollar/Norway NOK= 9.0093 9.1243 -1.26% +2.63% +9.1840 +9.0099
Euro/Norway EURNOK= 10.6395 10.7498 -1.03% +8.15% +10.8001 +10.6376
Dollar/Sweden SEK= 8.7492 8.8312 -0.61% -6.38% +8.8554 +8.7506
Euro/Sweden EURSEK= 10.3328 10.3966 -0.61% -1.30% +10.4160 +10.3329

(Reporting by Gertrude Chavez-Dreyfuss; Editing by Andrea Ricci and Dan Grebler)

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.